Results 61 to 70 of about 2,604,946 (316)

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Global Public Health Data Innovation [PDF]

open access: yes
CDC\u2019s Global Public Health Data Innovation (GPHDI) aims to address key barriers to effective use of data in public health response. This three-year initiative is supported by investment from the 2021 U.S. American Rescue Plan Act.

core  

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

CDC Center for Global Health 2017 annual report [PDF]

open access: yes
CS289084-AXPublication date from document properties.CGH_Annual-Report_2017-h.pdfAbout the Center for Global Health (CGH): Background and Organizational -- Structure -- Snapshot of CGH Accomplishments in 2017 -- Division of Global Health Protection (DGHP)

core  

Homing in on haemoglobinopathies

open access: yesThe Lancet Global Health, 2022
The Lancet Global Health
doaj   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Top ten global health priorities : Center for Global Health, U.S. Centers for Disease Control and Prevention, 2017 [PDF]

open access: yes
CS272346-AHPublication date from document properties.CDC_Global_Health_Photo_Book-web.pdf1. Working 24/7 TO PROTECT Americans from Global Health Threats -- 2. BOOTS ON THE GROUND : Responding to Global Health Emergencies -- 3.

core  

Taking the neglected out of neglected tropical diseases

open access: yesThe Lancet Global Health, 2020
The Lancet Global Health
doaj   +1 more source

Amplifying the global issue of hearing loss

open access: yesThe Lancet Global Health, 2022
The Lancet Global Health
doaj   +1 more source

Forecasting the Dialysis Burden in Japan: Validation‐Based Projections of Prevalence and Incidence Through 2050

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy